biotech

Hi, looking for scientist/senior scientist opportunities in the biotech/pharma industry. I’m a Biotechnology Scientist with 6+ years of experience in molecular biology, bioassay development, and drug discovery. Proficient in cutting-edge techniques such as ddPCR, RT-qPCR, high-throughput (HT)...

Hey Job Seekers- It's no surprise the market is a disaster right now. I'm a pharma/biotech recruiter focusing on the commercial side. I want to add resources for you, as most recruiters (from what I hear) are transactional and add little to no value. I'm here to change that. Here are a few...

Listed as salary plus bi-annual bonus. How likely is the bonus? How much is it? I have heard that it's a relatively "easy" job compared to other sales, but it seems there were a lot of issues back in 2016 specifically. Do they promote from within? Are raises possible? I haven't seen any...

NFL-101 is NFL Biosciences current core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins. 2 ongoing studies, a P2a with existing treatment and...

This morning an SSF Cell Therapy, currently on clinical trial, just laid off over 25%* of its employees. *Rumored quantity

In an exclusive interview with the AlphaStreet, ImmunoGen Inc (NASDAQ: IMGN) executive chief Mark Enyedy spoke about the company's product strategy, pipeline, and more. The pharma sector continues to be running on the tight budgets due to disruptive COVID-19 pandemic. However, ImmunoGen...

Hello, Dear forum members, While I am finishing my thesis, I am in lack of answers for my 5 min study and particularly from shareholders & biotech employes. I would appreciate a lote any help you could provide!! Pharmacist and student of Essec, I am finishing my master's thesis on the subject...

Clinical-stage biotech company Pfenex gets FDA's approval for PF708. Pfenex is conducting a comparative study between PF708 and Eli Lilly's Forteo and will submit the final study report to FDA later this month.

I am hearing that this company might be the next big thing. Anyone?

I expect that Amarin will bounce back from the recent sell-off. Most of the doctors who participated in the AHA event has said that they will prescribe Vascepa and next year the biggies like Pfizer might considering acquiring Amarin...

After announcing positive results for the treatment of cystic fibrosis, Proteostasis Therapeutics stock skyrocketed more than 400% and reached the double-digit mark after 18 months. https://news.alphastreet.com/proteostasis-therapeutics-stock-skyrockets-on-positive-cystic-fibrosis-trial-results/

There are rumors that Pfizer would take over Amarin, which skyrocketed today in the stock market as the cardiovascular study met primary and secondary endpoints using Vascepa drug. But Amarin has said that it's just a speculation...

Amgen earnings coverage With the recent launch of new products, sales improved 4% to $6.05 billion while profits jumped 17% touching $3.83 per share due to strong product sales. Free cash flow for the quarter came in at $1.9 billion, down 9.5% compared to last year due to increased tax outgo...

Investors have welcomed the move of Eli Lilly's decision to separate Elanco Animal Health business. Lilly stock hits a new 52-week high after the earnings announcement. David Ricks said, "As the responses to the Blueprint are considered, we are hopeful that progress will be made on implementing...

In the past two weeks, Celgene has reported positive results from 3 clinical trials. This includes two studies with its partner Acceleron. https://news.alphastreet.com/celgene-gets-a-booster-shot-from-recent-positive-clinical-trial-results/

Shares of biotech company Biogen (BIIB) rallied on Thursday during the after-hours trading after the company said it achieved positive results from final analysis of its Phase II trial of an Alzheimer’s drug. The advanced drug candidate, BAN2401, was developed in partnership with a Tokyo-based...

From leaders like Len/George to the lowest admin scum... https://www.streetinsider.com/Corporate+News/Merus+N.V.+%28MRUS%29+Says+U.S.+Court+of+Appeals+Denies+Regenerons+%28REGN%29+Petition+to+Rehear+the+Panels+Decision+on+018+Patent/13632058.html This article says it all. Do some more research...

https://alphastreet.com/bite/d578727 Amgen, that is in the process of refreshing its product portfolio, reported higher-than-expected 3Q profit, but sales declined in some of its biggest established products.

https://alphastreet.com/bite/d578727 Amgen, that is in the process of refreshing their product portfolios, reported higher-than-expected 3Q profit, but sales declined in some of its biggest established products.

Valeant has entered into an agreement to sell its Obagi Medical Products business for $190MM in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. $VRX intends to use the proceeds from the sale to permanently repay term loan debt under its Senior Secured Credit Facility...